Online citations, reference lists, and bibliographies.
← Back to Search

Surgical Treatment In The Management Of Malignant Pleural Mesothelioma: A Single Institution’s Experience

J. Sandick, I. Kappers, P. Baas, R. Haas, H. Klomp
Published 2008 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BackgroundA minority of patients with malignant pleural mesothelioma (MPM) are considered for surgery. To achieve a microscopically radical resection, combination with other treatment modalities is mandatory. The most effective combination is unknown. In our institute we have retrospectively analyzed the results of two combined modality regimens containing surgery.PatientsBetween January 2002 and September 2005, 15 MPM patients were treated with extrapleural pneumonectomy (EPP) and postoperative hemithoracic radiation (RT; 54 Gy). Previously, between January 1999 and December 2001, 20 patients underwent a combination of cytoreductive surgery – pleurectomy or EPP – and intraoperative hyperthermic intrathoracic chemotherapy (HITHOC), followed by radiotherapy to the thoracotomy scar and drainage tracts (24 Gy).ResultsThe median operating time for EPP/RT was shorter (5.3 versus 6.9 h; P < 0.0001). Postoperative complications occurred in 8 EPP/RT patients (53%) and in 14 HITHOC patients (70%). Two HITHOC patients died postoperatively. Median overall survival was 29 months for EPP/RT patients and 11 months for HITHOC patients (P = ns). The median time to local recurrence was not reached for EPP/RT patients, and was 9 months for HITHOC patients (P = 0.003). Local control was achieved in ten EPP/RT patients (67%) with a follow-up of 5–59 months compared to four HITHOC patients (20%) with a follow-up of 4–27 months.ConclusionsIn highly selected patients local control can be achieved with combination therapy but is accompanied by a high rate of (surgical) complications. Distant failure rates warrant further studies exploring the role of systemic chemotherapy while the use of cytoreductive surgery with intraoperative chemoperfusion for MPM is not supported.
This paper references
10.1097/00005382-200605000-00006
Preoperative Evaluation of Patients With Malignant Pleural Mesothelioma: Role of Integrated CT-PET Imaging
M. Truong (2006)
10.1378/CHEST.107.6_SUPPLEMENT.332S
Current approach to malignant mesothelioma of the pleura.
J. Aisner (1995)
5-year prospective results of trimodality treatment for malignant pleural mesothelioma.
V. Pagan (2006)
10.1067/MTC.2001.116560
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
V. Rusch (2001)
10.1038/sj.bjc.6690105
The European mesothelioma epidemic
J. Peto (1999)
10.1016/S0022-5223(99)70469-1
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
10.1378/CHEST.108.3.754
Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy.
C. Boutin (1995)
10.1245/ASO.2003.03.022
Cytoreductive Surgery Combined With Intraoperative Hyperthermic Intrathoracic Chemotherapy for Stage I Malignant Pleural Mesothelioma
S. van Ruth (2003)
10.1016/S0003-4975(03)00010-9
The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma.
J. H. Schouwink (2003)
10.1016/J.IJROBP.2006.03.012
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
A. Allen (2006)
10.1378/CHEST.108.4.1122
A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.
V. Rusch (1995)
10.1200/JCO.2005.04.6813
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
W. Richards (2006)
10.1016/J.EJCTS.2004.12.028
Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations.
D. Stewart (2005)
10.1067/MTC.2002.125817
Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma.
T. T. Lee (2002)
10.1016/J.CLON.2006.12.006
The role of radiotherapy in the treatment of malignant pleural mesothelioma.
K. Waite (2007)
10.1016/S1010-7940(02)00735-2
The management of malignant pleural mesothelioma.
G. Maggi (2003)
10.1016/S1010-7940(02)00273-7
The management of malignant pleural mesothelioma; single centre experience in 10 years.
T. Aziz (2002)
10.1056/NEJMRA050152
Advances in malignant mesothelioma.
B. Robinson (2005)
10.1016/J.THORSURG.2004.06.001
Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications.
M. Chang (2004)
10.1200/JCO.2003.11.136
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
N. Vogelzang (2003)
10.1378/CHEST.121.2.480
Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.
E. de Bree (2002)
10.1016/J.ATHORACSUR.2004.01.034
The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma.
D. Stewart (2004)
10.1016/J.ATHORACSUR.2005.06.014
Extended surgical staging for potentially resectable malignant pleural mesothelioma.
D. Rice (2005)
10.1016/J.JTCVS.2006.06.044
Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
M. D. de Perrot (2007)
Advances in malignant mesotheli
BW Robinson (2005)
10.1016/J.JTCVS.2004.02.021
Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies.
D. Sugarbaker (2004)
10.1016/J.CLON.2007.01.362
Intensity Modulated Radiotherapy to Deliver Hemithorax Irradiation for Mesothelioma for the MARS Trial
D. Gregory (2007)



This paper is referenced by
10.1097/JTO.0b013e3181ed0489
A Systematic Review of Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma
C. Cao (2010)
Management of malignant pleural effusion
R. Boshuizen (2017)
10.1007/s13193-018-0859-y
Hyperthermic Intrathoracic Chemotherapy (HITHOC) for Pleural Malignancies—Experience from Indian Centers
M. D. Patel (2018)
Oncotargets and Therapy
L. Yu ()
10.1007/978-3-030-40679-0_42
Intraoperative Accidents and Postoperative Complications in the Surgery of Pleural Tumours
M. Vayvada (2020)
10.1007/978-3-642-10862-4_7
Surgical therapy of mesothelioma.
D. Rice (2011)
10.1097/JTO.0b013e3182199819
Intensity-Modulated Radiotherapy After Extrapleural Pneumonectomy in the Combined-Modality Treatment of Malignant Pleural Mesothelioma
A. Chi (2011)
10.1510/icvts.2010.256289
Extrapleural pneumonectomy or supportive care: treatment of malignant pleural mesothelioma?
S. Sharif (2011)
10.1007/978-3-642-10862-4_8
Chemotherapy and radiotherapy for mesothelioma.
X. Dhalluin (2011)
State of the Art: Chirurgische Therapieoptionen beim malignen Pleuramesotheliom
T. Klikovits (2013)
10.1097/JTO.0b013e3181f1cf2b
Malignant Pleural Mesothelioma: A Population-Based Study of Survival
M. Milano (2010)
10.1002/jso.21230
Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei
T. Chua (2009)
10.21037/tlcr.2018.04.07
Proton beam therapy for malignant pleural mesothelioma.
S. Badiyan (2018)
Investigating the role of
C. Stevenson (2011)
10.3978/j.issn.2225-319X.2012.10.01
Radical surgery for malignant pleural mesothelioma: have we identified the appropriate selection tools?
N. van Zandwijk (2012)
10.1016/j.athoracsur.2011.02.062
Photodynamic therapy and the evolution of a lung-sparing surgical treatment for mesothelioma.
J. Friedberg (2011)
10.18632/oncotarget.22062
Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis
Z. Zhao (2017)
Best evidence topic - Thoracic oncologic Extrapleural pneumonectomy or supportive care: treatment of malignant pleural mesothelioma?
Sumera Sharif (2011)
10.1016/j.jtcvs.2014.10.128
Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma.
E. Baldini (2015)
10.1016/j.ijrobp.2009.06.037
Radiotherapy in malignant pleural mesothelioma.
M. McAleer (2009)
10.1007/s13566-014-0142-y
Impact of intensity-modulated radiation therapy on outcomes for malignant pleural mesothelioma treated with trimodality therapy
E. Murphy (2014)
10.1183/09031936.00153611
Population-based survival for malignant mesothelioma after introduction of novel chemotherapy
R. Damhuis (2011)
10.21037/JTD.2019.04.93
Pleurectomy/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma.
L. Klotz (2019)
10.1016/B978-1-4160-5225-8.00046-5
Innovative Therapy and Technology
Joseph J. Wizorek (2010)
10.1097/MD.0000000000005532
Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion
H. Zhou (2017)
10.1007/978-3-030-16884-1_13
Surgery and Multimodality Treatment in Malignant Pleural Mesothelioma
F. Rea (2019)
10.2147/OTT.S41347
Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination
L. Yu (2013)
10.1080/17476348.2017.1338951
Induction chemotherapy vs post-operative adjuvant therapy for malignant pleural mesothelioma
G. Marulli (2017)
Semantic Scholar Logo Some data provided by SemanticScholar